CD4 and tuberculosis: The findings of this meta-analysis indicate that BGD, in combination with anti-TB Chemotherapy, can significantly increase CD4+ T lymphocyte subset levels, suggesting an immunomodulatory effect (Yang et al., 2021; Xie et al., 2023).